Plasmid construct development is a critical step in enabling downstream synthetic biology and therapeutic programs—but it’s often slowed by limited throughput, manual workflows, and delayed data insights.
In this webinar, we explore how smart, cloud-connected bioreactors are transforming plasmid development by enabling parallel experimentation, real-time monitoring, and faster decision-making. By combining automated bioreactor systems with integrated software, teams can accelerate construct optimization, improve reproducibility, and reduce time to results.